Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis Vaccines”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04152161
What this trial is testing

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

Who this might be right for
Tuberculosis
Gates Medical Research Institute 1,836
Testing effectiveness (Phase 2)Study completedNCT01098474
What this trial is testing

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants

Who this might be right for
Tuberculosis
GlaxoSmithKline 301
Early research (Phase 1)Not Yet RecruitingNCT07647107
What this trial is testing

A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations

Who this might be right for
TuberculosisTB Infection
PT Bio Farma 60
Early research (Phase 1)Study completedNCT01683773
What this trial is testing

Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A

Who this might be right for
Tuberculosis
University of Oxford 40
Early research (Phase 1)Study completedNCT04563273
What this trial is testing

Clinical Study of BCG Vaccine for Intradermal Injection

Who this might be right for
Tuberculosis
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 160
Early research (Phase 1)Study completedNCT00929396
What this trial is testing

A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers

Who this might be right for
Tuberculosis
Statens Serum Institut 20
Early research (Phase 1)Study completedNCT01113281
What this trial is testing

Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa

Who this might be right for
Tuberculosis
Serum Life Science Europe GmbH 24
Testing effectiveness (Phase 2)Study completedNCT00707967
What this trial is testing

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Who this might be right for
Tuberculosis
GlaxoSmithKline 37
Early research (Phase 1)Active Not RecruitingNCT06050356
What this trial is testing

First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b

Who this might be right for
Healthy
Statens Serum Institut 140
Testing effectiveness (Phase 2)Study completedNCT00146744
What this trial is testing

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Who this might be right for
Tuberculosis (TB)
GlaxoSmithKline 38
Not applicableUnknownNCT05820594
What this trial is testing

Using BCG Vaccine to Understand Tuberculosis Infection

Who this might be right for
Tuberculosis
Liverpool School of Tropical Medicine 30
Early research (Phase 1)Study completedNCT00653770
What this trial is testing

A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A

Who this might be right for
Tuberculosis
University of Oxford 31
Testing effectiveness (Phase 2)Study completedNCT00621322
What this trial is testing

Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults

Who this might be right for
Tuberculosis
GlaxoSmithKline 180
Testing effectiveness (Phase 2)Study completedNCT01198366
What this trial is testing

Study of AERAS-402 in Healthy Infants

Who this might be right for
Tuberculosis
Aeras 487
Testing effectiveness (Phase 2)Active Not RecruitingNCT06272812
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

Who this might be right for
Tuberculosis (TB)
International AIDS Vaccine Initiative 5,500
Early research (Phase 1)Study completedNCT02508376
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 70
Large-scale testing (Phase 3)Study completedNCT03947138
What this trial is testing

GC3107(BCG Vaccine) in Healthy Infants

Who this might be right for
BCG Vaccination ReactionTuberculosis
Green Cross Corporation 750
Early research (Phase 1)UnknownNCT03363178
What this trial is testing

Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults

Who this might be right for
Tuberculosis
Green Cross Corporation 20
Early research (Phase 1)Ended earlyNCT00800670
What this trial is testing

Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine

Who this might be right for
Tuberculosis
McMaster University 24
Testing effectiveness (Phase 2)Study completedNCT06873282
What this trial is testing

Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine

Who this might be right for
Tuberculosis
Research Institute of Influenza, Russia 160
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation